China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

CBPO 98.59 -0.35 (-0.35%)
price chart
New Lifetime High Reached By China Biologic Products (CBPO)
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
Today's Insights: China Biologic Products, Inc. (CBPO), Boise Cascade ...  WallStreet Scope
China Biologic Products Q4 2014 Earnings: Primed For A Sell-Off? (CBPO)
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Trade-Ideas: China Biologic Products (CBPO) Is Today's New Lifetime High Stock
China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China.
China Biologic Products Earnings Preview (CBPO)
China Biologic Products (NASDAQ: CBPO), a biopharmaceutical company focused on developing plasma-based products, has been subjected to a roller coaster ride over the last several months. Back in mid June, shares fell more than 11% after the ...
Related articles »  
China Biologic Products, Inc. (CBPO) Rises: Stock Jumps 7.4%
China Biologic Products, Inc. (CBPO - Snapshot Report) was a big mover last session, as the company saw its shares rise more than 7% on the day.
Related articles »  
China Biologic Products, Inc. (CBPO) Jumps: Stock Surges 10.8%
China Biologic Products, Inc. (CBPO - Snapshot Report) was a big mover last session, as the company saw its shares rise nearly 11% on the day.
Related articles »  
Update: China Biologic Products Adopts Stockholder Plan To Avoid Hostile ...
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Update: China Biologic Products Q3 Earnings Beat (CBPO)
Before Q2 earnings on August 5, I wrote a bullish article on China Biologic Products (NASDAQ:CBPO), with a thesis stating that the company's plasma-based products should benefit from increasing market demand in China for Q2. I argued that the company's ...
Related articles »  
Stock in Focus : China Biologic Products, Inc. (NASDAQ:CBPO)
China Biologic Products, Inc. (NASDAQ:CBPO) (TREND ANALYSIS) shares were traded with more than 50% increase in usual volume.
China Biologic Products CBPO) Falls: Stock Goes Down 6%
China Biologic Products, Inc. (CBPO - Snapshot Report) saw a big move last session, as the company's shares fell nearly 6% on the day.